Cryopreservation is not unique to iMSC — it is a shared challenge across almost all cell therapy workflows.
But for off-the-shelf iMSC development, this step becomes especially important.
Why?
Because the product model itself depends on cells being frozen, stored, transported and then used after thaw. So the question is not simply whether iMSCs can be generated and expanded at scale. It is also whether they can maintain viability, consistency and functionality after freeze–thaw. That is why cryopreservation is more than a storage step.
For off-the-shelf iMSC products, it is closely linked to product stability, manufacturing consistency and downstream usability.
At CellStore, we are addressing this challenge through CS-DX-N2 (DMSO-Free Stem Cell Cryopreservation Medium), developed to better support post-thaw performance in cell therapy workflows.
Cryopreservation Solution：
Control ice crystal formation
Maintain osmotic balance
Protect post-thawcell function
Learn more CS-DX-N2, Contact us.
